Characterisation of methicillin-resistant Staphylococcus aureus with reduced susceptibility to teicoplanin in Eastern France.

Suppr

超能文献

作者信息

Bertrand X, Hocquet D, Thouverez M, Plésiat P, Talon D

机构信息

Service d'Hygiène hospitalière et d'Epidémiologie moléculaire, CHU Jean Minjoz, 25030, Besançon, France.

出版信息

Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):504-6. doi: 10.1007/s10096-003-0966-7. Epub 2003 Jul 12.

DOI:10.1007/s10096-003-0966-7

PMID:12884064

Abstract

摘要

相似文献

Characterisation of methicillin-resistant Staphylococcus aureus with reduced susceptibility to teicoplanin in Eastern France.

Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):504-6. doi: 10.1007/s10096-003-0966-7. Epub 2003 Jul 12.

Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection.

J Antimicrob Chemother. 2002 Feb;49(2):423-4. doi: 10.1093/jac/49.2.423.

Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.

Clin Microbiol Infect. 2004 May;10(5):459-61. doi: 10.1111/j.1469-0691.2004.00878.x.

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.

Clin Microbiol Infect. 2004 May;10(5):448-51. doi: 10.1111/j.1469-0691.2004.00830.x.

[Methicillin resistant staphylococci].

Antibiot Khimioter. 1998;43(6):29-31.

[Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].

Recenti Prog Med. 2003 Jul-Aug;94(7-8):344.

[Problems with teicoplanin in the treatment of osteoarticular infections caused by methicillin-resistant S. aureus].

Enferm Infecc Microbiol Clin. 1992 Nov;10(9):567-8.

Failure of teicoplanin therapy in Staphylococcus aureus septicaemia.

J Hosp Infect. 1994 Dec;28(4):325-7. doi: 10.1016/0195-6701(94)90098-1.

An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.

Clin Infect Dis. 2000 Nov;31(5):1306-8. doi: 10.1086/317464.

In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.

BMC Infect Dis. 2007 Sep 21;7:111. doi: 10.1186/1471-2334-7-111.

引用本文的文献

A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model.

Front Immunol. 2021 Jul 2;12:676534. doi: 10.3389/fimmu.2021.676534. eCollection 2021.

Newer treatment options for skin and soft tissue infections.

Drugs. 2004;64(15):1621-42. doi: 10.2165/00003495-200464150-00002.

本文引用的文献

[Endemic heteroresistant glycopeptide intermediate Staphylcoccus aureus (hGISA) comprising unrelated clonal types and not associated with vancomycin therapy].

Pathol Biol (Paris). 2002 Nov;50(9):525-9. doi: 10.1016/s0369-8114(02)00345-0.

Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.

MMWR Morb Mortal Wkly Rep. 2002 Oct 11;51(40):902.

A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics.

J Antimicrob Chemother. 2002 Aug;50(2):171-5. doi: 10.1093/jac/dkf117.

Staphylococcus aureus resistant to vancomycin--United States, 2002.

MMWR Morb Mortal Wkly Rep. 2002 Jul 5;51(26):565-7.

Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection.

J Antimicrob Chemother. 2002 Feb;49(2):423-4. doi: 10.1093/jac/49.2.423.

Clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin in Northwest England.

J Antimicrob Chemother. 2001 Sep;48(3):454-5. doi: 10.1093/jac/48.3.454.

Antibiotic susceptibility and genotypic characterization of methicillin-resistant Staphylococcus aureus strains in eastern France.

J Hosp Infect. 2000 Dec;46(4):280-7. doi: 10.1053/jhin.2000.0841.

Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital.

J Clin Microbiol. 2000 Aug;38(8):2985-8. doi: 10.1128/JCM.38.8.2985-2988.2000.

The biological cost of antibiotic resistance.

Curr Opin Microbiol. 1999 Oct;2(5):489-93. doi: 10.1016/s1369-5274(99)00005-3.

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital.

Lancet. 1998 Apr 18;351(9110):1212. doi: 10.1016/s0140-6736(05)79166-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验